Company intelligence / Profile preview

Baudax Bio

Malvern, Pennsylvania, United Statesbaudaxbio.com ↗

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Baudax Bio’s lead product ANJESO® (IV meloxicam) is FDA-approved for moderate to severe pain. The company’s pipeline includes two novel neuromuscular blocking agents—BX1000 in Phase II and BX2000 in Phase I—and a proprietary reversal agent in preclinical development. Recent clinical data show that BX1000 met primary efficacy endpoints with safety comparable to standard-of-care rocuronium. The company has also explored Treg-based cell therapies for autoimmune diseases but the main focus remains acute care pharmaceuticals

Therapeutic areas: OtherImmunologyNeurology
Modalities: Small molecules (e.g., meloxicam/ANJESO)neuromuscular blocking agents (NMBs)cell therapy (Treg-based therapies)
Industry: Biotech

Drug pipeline

6 assets

Anjeso

Approved

5 more assets in the full pipeline.

Partnerships

Licensing agreement with Cornell University for NMB assets; no major pharma partnerships disclosed publicly as of latest filings.

Beyond the preview

Go deeper on Baudax Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baudax Bio.